Indication

Choroidal neovascularization

Choroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space. Read more about Choroidal neovascularization

8 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Choroidal neovascularization therapies.

Showing 1–8 of 8 drugs

VISUDYNE (verteporfin)

OPHTHALMIC - PHOTODYNAMIC THERAPY AGENTS·CHOROIDAL NEOVASCULARIZATION·+3
Bausch Health US

VISUDYNE (verteporfin)

OPHTHALMIC - PHOTODYNAMIC THERAPY AGENTS·CHOROIDAL NEOVASCULARIZATION·+3
BAUSCH & LOMB P
Filter & compare in the drug finder →Opens the drug finder with Choroidal neovascularization preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Choroidal neovascularization.

Choroidal neovascularization is an ocular condition characterized by the abnormal proliferation of immature, pathological blood vessels arising from the choriocapillaris that penetrate Bruch’s membrane into the subretinal pigment epithelium or subretinal space.

It primarily affects adults with underlying retinal disorders, serving as the hallmark of wet age-related macular degeneration and a major sight-threatening complication in pathologic myopia, ocular histoplasmosis, or inflammatory chorioretinopathies.

Clinically, these immature vessels are fragile and hyperpermeable, leading to intraretinal or subretinal exudation, hemorrhage, retinal pigment epithelial detachment, and subsequent fibrovascular scarring that causes rapid, severe loss of central visual acuity.

Personalize your experience

Follow Choroidal neovascularization and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it